-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
CymaBay Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q4 2023.
- CymaBay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $4.67M, a 97.8% increase year-over-year.
- CymaBay Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $15.2M, a 60% increase year-over-year.
- CymaBay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.2M, a 60% increase from 2022.
- CymaBay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.52M, a 4.79% decline from 2021.
- CymaBay Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10M, a 36.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)